Mortality within the longest · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids showed no clear difference in all‐cause mortality (during the index hospital admission, or within… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Subgroup analysis of longer‐term mortality: enrolment ≤ 48 hours after entry criteria/ventilationAlive or dead · adults with acute respiratory failure
Mortality: prone position probably leads to lower subgroup analysis of longer‐term mortality: enrolment ≤ 48 hours… compared with supine (moderate certainty).
1 finding from 1 review
Long‐term mortality (time‐to‐event outcome): radiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes long‐term mortality (time‐to‐event outcome): radiotherapy versus… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Long‐term mortality (time‐to‐event outcome): chemoradiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (time‐to‐event outcome): chemoradiotherapy… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
All‐cause mortality (deaths) Â · COPD and at least one other long‐term condition
It is very uncertain whether intervention changes all‐cause mortality (deaths) Â compared with usual care (very low certainty).
1 finding from 1 review
Death from any cause (secondary outcome 3) · Mechanically ventilated adults in the intensive care unit
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality: time‐point not defined · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: time‐point not defined compared with longer storage duration (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality · patients undergoing abdominal or pelvic surgery
The intervention showed no clear difference in mortality (moderate certainty).
1 finding from 1 review
All‐cause mortality · older people with dementia who had been taking an antipsychotic drug for at least 3 months
1 finding from 1 review
Intervention not reported
Mortality · patients with COPD
The intervention leads to lower mortality (high certainty).
1 finding from 1 review
All‐cause mortality · COPD
Combined inhalers showed no clear difference in mortality compared with LABAs (moderate certainty).
1 finding from 1 review
Mortality: short term (up to 30 days) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: short term (up to 30 days) compared with longer storage duration (low certainty).
1 finding from 1 review
Mortality (treatment duration 3 months) · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE
LMWH showed no clear difference in mortality (treatment duration 3 months) compared with VKA (moderate certainty).
1 finding from 1 review
All‐cause mortality (30 days post‐surgery) · people undergoing definitive fixation of hip, pelvic and long bone fractures
Intravenous tranexamic acid showed no clear difference in all‐cause mortality (30 days post‐surgery) compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality (30 days post‐surgery) · people undergoing definitive fixation of hip, pelvic and long bone fractures
It is very uncertain whether topical tranexamic acid changes all‐cause mortality (30 days post‐surgery) compared with placebo (very low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (within 7 days) · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: in‐hospital mortality (within 7 days) compared with longer storage duration (very low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (within 24 hours) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐hospital mortality (within 24 hours) compared with longer storage duration (low certainty).
1 finding from 1 review
Mortality Deaths · patients with chronic obstructive pulmonary disease
Indacaterol showed no clear difference in mortality Deaths compared with twice‐daily long‐acting beta2‐agonists (moderate certainty).
1 finding from 1 review
Patient mortality · nurses working on medical or long‐term psychiatric units
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found